These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37160771)

  • 1. Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study.
    Dávila I; Puente L; Quirce S; Arismendi E; Díaz-Palacios M; Pereira-Vega A; de Diego A; Rodriguez-Hermosa JL; Cea-Calvo L; Sánchez-Jareño M; López-Cotarelo P; Domingo C
    Lung; 2023 Jun; 201(3):275-286. PubMed ID: 37160771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported experiences with refractory or unexplained chronic cough: a qualitative analysis.
    Bali V; Schelfhout J; Sher MR; Tripathi Peters A; Patel GB; Mayorga M; Goss D; Romano CD
    Ther Adv Respir Dis; 2024; 18():17534666241236025. PubMed ID: 38501735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis.
    Domingo C; Fernandez M; Garin N; Milara J; Moran I; Muerza I; Pacheco A; Teruel C; Bentley R; Subiran R; Gil A
    Appl Health Econ Health Policy; 2023 Jan; 21(1):119-130. PubMed ID: 36319945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic cough].
    Kardos P
    Pneumologie; 2023 Aug; 77(8):574-585. PubMed ID: 37619576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A register-based study: cough - a frequent phenomenon in the adult population.
    Backer V; Porsborg A; Hansen V; Skjold T; Schmid JM; Kehlet M; Torp-Pedersen C; Aasbjerg K
    BMC Pulm Med; 2022 Nov; 22(1):426. PubMed ID: 36401236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding physician's knowledge and perception of chronic cough in Switzerland.
    Leuppi JD; Guggisberg P; Koch D; Favre-Bulle A; Fabiani M; Heinz S; Zeller A
    Curr Med Res Opin; 2022 Aug; 38(8):1459-1466. PubMed ID: 35369836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An observational study to understand burden and cost of care in adults diagnosed with refractory chronic cough (RCC) or unexplained chronic cough (UCC).
    Smith JA; Stein N; Migas S; Bokowski S; Williams C; Baker P; New J; Schelfhout J; Fonseca E; Langerman H
    Respir Res; 2024 Jul; 25(1):265. PubMed ID: 38965601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview study.
    Martin Nguyen A; La Rosa C; Cornell AG; Sher MR; Bernstein JA; Birring SS; DeMuro Romano C; Mayorga M; Milien M; Ervin C
    Ther Adv Respir Dis; 2024; 18():17534666241274261. PubMed ID: 39235438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough.
    Dicpinigaitis PV; Birring SS; Blaiss M; McGarvey LP; Morice AH; Pavord ID; Satia I; Smith JA; La Rosa C; Li Q; Nguyen AM; Schelfhout J; Tzontcheva A; Muccino D
    Ann Allergy Asthma Immunol; 2023 Jan; 130(1):60-66. PubMed ID: 35569802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics, demographics, and epidemiology of possible chronic cough in Sweden: A nationwide register-based cohort study.
    Walz L; Illergård K; Arpegård J; Dorbesi C; Johansson H; Ingi Emilsson Ö
    PLoS One; 2024; 19(7):e0303804. PubMed ID: 39047005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing unmet needs for diagnosis and management of chronic cough in the primary care setting.
    Kardos P; Blaiss M; Dicpinigaitis P
    Postgrad Med; 2021 Jun; 133(5):481-488. PubMed ID: 33830846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant.
    Morice AH; Birring SS; Smith JA; McGarvey LP; Schelfhout J; Martin Nguyen A; Xu ZJ; Wu WC; Muccino DR; Sher MR
    Lung; 2021 Apr; 199(2):121-129. PubMed ID: 33825965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of Disease Associated with Refractory and Unexplained Chronic Cough in Canada: Results from a National Survey.
    Brister D; Khan S; Abraham T; Laventure S; Sahakian S; Juliá B; Satia I
    Lung; 2024 Aug; 202(4):415-424. PubMed ID: 38867086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient satisfaction with the management of refractory and unexplained chronic cough in Canada: Results from a national survey.
    Khan S; Brister D; Abraham T; Laventure S; Sahakian S; Juliá B; Satia I
    PLoS One; 2024; 19(8):e0308275. PubMed ID: 39088459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Unexplained Chronic Cough: CHEST Guideline and Expert Panel Report.
    Gibson P; Wang G; McGarvey L; Vertigan AE; Altman KW; Birring SS;
    Chest; 2016 Jan; 149(1):27-44. PubMed ID: 26426314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study.
    Zhang M; Morice AH; Si F; Zhang L; Chen Q; Wang S; Zhu Y; Xu X; Yu L; Qiu Z
    Ther Adv Respir Dis; 2023; 17():17534666231167716. PubMed ID: 37078383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insights Into Refractory Chronic Cough and Unexplained Chronic Cough: A 6-Year Ambispective Cohort Study.
    Zhang M; Morice AH; Si F; Zhang L; Chen Q; Wang S; Zhu Y; Xu X; Yu L; Qiu Z
    Allergy Asthma Immunol Res; 2023 Nov; 15(6):795-811. PubMed ID: 37957796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase 3, randomized, double-blind, clinical study to evaluate the long-term safety and efficacy of gefapixant in Japanese adult participants with refractory or unexplained chronic cough.
    Niimi A; Sagara H; Kikuchi M; Arano I; Sato A; Shirakawa M; La Rosa C; Muccino D
    Allergol Int; 2022 Oct; 71(4):498-504. PubMed ID: 35752582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging drugs in the treatment of chronic cough.
    Brister D; Wahab M; Rashad M; Diab N; Kolb M; Satia I
    Expert Opin Emerg Drugs; 2023 Dec; 28(2):67-77. PubMed ID: 37060576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough.
    Mazzone SB; McGarvey L
    Clin Pharmacol Ther; 2021 Mar; 109(3):619-636. PubMed ID: 32748976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.